Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsatas, D.
Right arrow Articles by Rice, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsatas, D.
Right arrow Articles by Rice, G. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry, Vol. 45, 1593-1602, Copyright © 1997 by The Histochemical Society, Inc.


ARTICLE

Tissue-specific Expression of the Relaxed Conformation of Plasminogen Activator Inhibitor-2 and Low-density Lipoprotein Receptor-related Protein in Human Term Gestational Tissues

Dina Tsatasa, Mark S. Bakerb, and Gregory E. Ricea
a Department of Perinatal Medicine, Royal Women's Hospital and Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia
b Department of Biological Sciences, University of Wollongong, New South Wales, Australia

Correspondence to: Dina Tsatas, Dept. of Perinatal Medicine, Perinatal Research Centre, The Royal Women’s Hospital, Carl-ton, Victoria, Australia 3053.

The relaxed conformation of plasminogen activator inhibitor-2 (PAIr) is formed during inactivation of the matrix-degrading enzyme urokinase plasminogen activator (uPA). The presence of PAIr in tissues, therefore, indicates the in situ inhibition of uPA-mediated proteolysis. In addition, PAIr functions as a ligand for the clearance receptor low-density lipoprotein receptor-related protein (LRP), thereby promoting internalization of receptor-bound uPA-PAIr complexes from the cell surface. The rapid internalization of receptor-bound, inactivated uPA has been suggested to be characteristic of invasive cell phenotypes. The aims of this study were to characterize the immunohistochemical localization of PAIr in human term gestational tissues (amnion, choriodecidua, and placenta) and to establish its co-expression with other components of the uPA cascade. The results obtained indicate that PAIr immunoreactivity was exclusively localized to amnion epithelial cells, with only minimal staining in the underlying chorion. PAIr immunoreactivity was not detectable in any of the trophoblastic tissues examined (villous and extravillous). The tissue-specific expression of PAIr immunoreactivity was not significantly altered in association with labor onset. uPA and PAI-2 staining was localized predominantly to amnion epithelial cells, underlying chorion, and trophoblast cells of villous and extravillous tissue. Amnion and trophoblasts of extravillous and chorionic tissue showed uPAR immunoreactivity, whereas staining in placenta was absent. Immunoreactive LRP was confined to trophoblasts of the chorion, and the villous and extravillous tissue. For the first time, localization of PAIr at the tissue level has been identified. The data obtained are consistent with the hypothesis that cells of invasive phenotype, although expressing all components of the uPA cascade, do not accumulate immunoreactive PAIr, because it is rapidly internalized from the cell surface. Conversely, cells of noninvasive phenotype will accumulate PAIr immunoreactivity only in the absence of LRP expression. We propose that the presence of PAIr and the absence of LRP at the cell surface are putative markers of noninvasive phenotypes. (J Histochem Cytochem 45:1593-1602, 1997)

Key Words: gestational tissue, immunohistochemistry, matrix remodeling, plasminogen activation cascade


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Yin, J. Lockett, Y. Meng, H. Biliran Jr., G. E. Blouse, X. Li, N. Reddy, Z. Zhao, X. Lin, J. Anagli, et al.
Maspin Retards Cell Detachment via a Novel Interaction with the Urokinase-Type Plasminogen Activator/Urokinase-Type Plasminogen Activator Receptor System.
Cancer Res., April 15, 2006; 66(8): 4173 - 4181.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. L. S. Lindegaard, G. Olivecrona, C. Christoffersen, D. Kratky, J. Hannibal, B. L. Petersen, R. Zechner, P. Damm, and L. B. Nielsen
Endothelial and lipoprotein lipases in human and mouse placenta
J. Lipid Res., November 1, 2005; 46(11): 2339 - 2346.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Radunovic, E. Kuczynski, T. Rosen, J. Dukanac, S. Petkovic, and C. J. Lockwood
Plasma Apolipoprotein A-I and B Concentrations in Growth-Retarded Fetuses: A Link between Low Birth Weight and Adult Atherosclerosis
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 85 - 88.
[Abstract] [Full Text]


Home page
IOVSHome page
D. L. Williams, B. Risse, S. Kim, D. Saunders, S. Orlin, M. S. Baker, P. J. Jensen, and R. M. Lavker
Plasminogen Activator Inhibitor Type 2 in Human Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. N. Saunders, K. M. L. Buttigieg, A. Gould, V. McPhun, and M. S. Baker
Immunological Detection of Conformational Neoepitopes Associated with the Serpin Activity of Plasminogen Activator Inhibitor Type-2
J. Biol. Chem., May 1, 1998; 273(18): 10965 - 10971.
[Abstract] [Full Text] [PDF]




Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 1997